Marketplace / Healthtech / Pre-Seed
Apricell Biotechnology
“Redefining the future of drug development by integrating human-relevant tissue models.”
Overview
Apricell Biotechnology develops predictive in vitro models for drug discovery and oncology research. The company utilizes organoid-on-a-chip technology and intelligent data analytics to enhance therapeutic discovery and reduce clinical trial risks.
Traction
as reported by the founderTraditional drug development often relies on models that fail to accurately predict human responses, leading to high rates of clinical trial failure.
Apricell provides high-throughput, predictive systems using organoid and organoid-on-a-plate technologies to create human-relevant tissue models for more effective drug screening.
Company updates
No updates posted yet.
Follow this company
Get an email when Apricell Biotechnology posts an update. No account needed — one click to unsubscribe.
Achievements
Apricell Biotechnology
Deck · financials · founder contact